The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University.

The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University. - The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038335

Enrollment

150

Registered

2019-10-21

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated age-related macular degeneration patients started the treatment of aflibercept injection during study period

Exclusion criteria

Exclusion criteria: 1) The patient who had a history of treatment using anti-VEGF agents, 2) The patient who entry to other intervention study

Design outcomes

Primary

Measure	Time frame
Change of visual acuity at 2nd year after starting treatment	—

Secondary

Measure	Time frame
The treatment interval of aflibercept at 2nd year after starting treatment	—

Countries

Japan

Contacts

Public ContactMakiko Wakuta

Yamaguchi University graduate school of medicine Department of Ophthalmology

mwakut@yamaguchi-u.ac.jp0836-22-2278

Outcome results